Breaks Categories: News

ThursdaySep 04, 2025 9:20 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures $5.3 Million from Warrant Exercises to Advance AVERSA Fentanyl NDA

Nutriband (NASDAQ: NTRB), a company developing abuse deterrent pharmaceutical products, announced the exercise of warrants at a strike price of $6.43, generating $5,306,000 in proceeds. The funds will support the remaining clinical development of AVERSA Fentanyl and submission of its New Drug Application (NDA) with the U.S. Food and Drug Administration. AVERSA Fentanyl, which could become the world’s first opioid patch with abuse deterrent properties, is estimated to reach peak annual U.S. sales of $80 million to $200 million, according to a 2022 Health Advances market analysis report. To view the full press release, visit https://nnw.fm/EspWP About Nutriband Inc. We…

Continue Reading

ThursdaySep 04, 2025 9:00 am

NetworkNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Launches Redesigned Corporate Website to Mark Turnaround and Growth Phase

SEGG Media (NASDAQ: SEGG, LTRYW), a sports, entertainment and gaming conglomerate that owns Sports.com, Concerts.com and Lottery.com, announced the launch of its newly redesigned corporate website, seggmediacorp.com, a digital hub signaling the completion of the Company’s turnaround and the start of its next phase of growth. The site highlights SEGG Media’s evolution into a content-first platform focused on fan engagement, younger audiences and immersive digital experiences, while centralizing access to Sports.com, Concerts.com and Lottery.com. The relaunch underscores SEGG Media’s unified corporate identity, investor transparency, fan engagement initiatives and ecosystem integration, positioning the Company as a forward-thinking media brand built for…

Continue Reading

WednesdaySep 03, 2025 1:45 pm

NetworkNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial 

Lantern Pharma (NASDAQ: LTRN), an AI-driven clinical-stage oncology company, announced the completion of a Type C meeting with the U.S. Food and Drug Administration, which provided guidance on the regulatory pathway and design of a planned pediatric trial targeting CNS cancers, including Atypical Teratoid Rhabdoid Tumor (ATRT). The FDA supported Lantern’s proposal for a parallel ATRT cohort and the potential inclusion of spironolactone as a combination agent with LP-184/STAR-001, the company’s lead investigational therapy. Lantern, through its subsidiary Starlight Therapeutics, will submit an IND amendment reflecting the feedback, with trial initiation targeted for Q1 2026. The program holds Rare Pediatric…

Continue Reading

WednesdaySep 03, 2025 1:33 pm

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Spotlighted in Forbes Feature on AI and Web3 Convergence

Datavault AI (NASDAQ: DVLT), a leader in tokenized data and Web3 infrastructure, was recently featured in Forbes in an article titled “How AI Is Ushering In A New Age For Web3” (Aug. 31, 2025). The piece highlights DVLT’s role in merging blockchain’s decentralized architecture with the adaptive intelligence of AI, underscoring how its secure, user-centric data platform enables seamless integration of tokenized assets and personalized digital interactions. As enterprises and developers look to bridge trust, transparency, and efficiency across decentralized ecosystems, DVLT is positioning itself as a cornerstone for the next generation of Web3 infrastructure. The Forbes coverage emphasized that…

Continue Reading

WednesdaySep 03, 2025 1:10 pm

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join H.C. Wainwright’s 27th Annual Global Investment Conference; CEO Fireside Chat Set for Sept. 8, 2025, 4:30 to 5 p.m. ET

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc. (“HOPE”), an interventional psychiatry network wholly owned by NRx Pharmaceuticals, announced that Chairman and CEO Jonathan Javitt, M.D., M.P.H., will participate in a fireside chat at H.C. Wainwright’s 27th Annual Global Investment Conference on Monday, Sept. 8, 2025, from 4:30 to 5 p.m. ET. A webcast will be available on the Events page of the Investors section of the Company’s website, with a replay posted two hours after the event for 30 days. To view the full press release, visit https://nnw.fm/1yX7W About NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc.…

Continue Reading

WednesdaySep 03, 2025 1:00 pm

NetworkNewsBreaks – Ucore Rare Metals Inc. (TSXV: UCU) (OTCQX: UURAF) Completes Automatic Conversion of Remaining $1.1M Convertible Debentures

Ucore Rare Metals (TSXV: UCU) (OTCQX: UURAF), a company focused on rare earth element separation and supply chain innovation, announced that the final $1.1 million of convertible debentures issued in May 2020 have been automatically converted into equity following the triggering of a conversion clause tied to the Company’s share price performance. With this automatic conversion, Ucore issued 1,222,219 common shares and 611,108 warrants, and no debentures remain outstanding. Originally, 2,800 debentures were issued at $1,000 each with 7.5% annual interest, later amended in 2024 to mature on Jan. 31, 2026, with a conversion price of $0.90 per unit. The…

Continue Reading

WednesdaySep 03, 2025 12:02 pm

NetworkNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Expands Fast Motion Shaft Availability to Club Champion Locations Nationwide

Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering performance-driven innovations through physics-based engineering, announced that its Fast Motion shafts are now available for fitting and purchase at Club Champion, a leading U.S. club fitting retailer with more than 130 locations. Building on momentum from its flagship Motion series, the rollout expands access to one of golf’s fastest-growing shaft technologies. Launched April 29, 2025, the Fast Motion shaft has already outperformed expectations, with nearly 4,000 units and approximately $1.4 million in orders to date, driven by demand from both professionals and amateurs. Featuring high-modulus Toray carbon fibers, the shaft…

Continue Reading

WednesdaySep 03, 2025 10:31 am

NetworkNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Closes $31 Million Acquisition of Holiday Inn Property to Launch AI-Driven Hospitality Platform

Nightfood Holdings (OTCQB: NGTF), a hospitality technology company leveraging AI-powered robotics and strategic acquisitions to transform hotel operations, announced the closing of its $31 million share exchange agreement to acquire Victorville Treasure Holdings, LLC, owner of a 155-room Holiday Inn in Victorville, Calif. The deal marks Nightfood’s first completed hotel acquisition, with a second nearing completion, and establishes the Victorville property as the Company’s Robotics-as-a-Service innovation site. Initial automation solutions, including Skytech’s Laundry Helper robot, have already been deployed, with future phases to expand across housekeeping, foodservice, and front-of-house functions to create a scalable “Smart Hotel” model. CEO Jimmy Chan…

Continue Reading

WednesdaySep 03, 2025 9:50 am

NetworkNewsBreaks – Green Rain Energy Holdings Inc. (OTC: GREH) Signs MOU with Allied Energy to Power EV Charging Corridors in Southwest

Green Rain Energy Holdings (OTC: GREH), an ESCO company developing EV charging sites and solar farms nationwide, announced a Memorandum of Understanding with Allied Energy Corporation (OTC: AGYP) to supply BTU-validated natural gas from producing wells for off-grid and hybrid EV charging stations in Texas, New Mexico, and other Southwestern states. The agreement addresses grid constraints amid rising EV adoption by enabling rapid, modular charging infrastructure deployment. “This agreement is a game-changer,” said Alfredo Papadakis, President of Green Rain. “It gives us clean, flexible energy input for rapid EV infrastructure buildout—without waiting years for utility interconnects.” To view the full…

Continue Reading

WednesdaySep 03, 2025 9:30 am

NetworkNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Secures Exclusive U.S. Patent for Computer-Aided Diagnosis with Breast CT

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing imaging-based technologies for improved breast cancer screening, diagnosis, and treatment, announced the issuance of the only U.S. patent for computer-aided diagnosis (CADx) with breast CT, covered under the Company’s exclusive global license agreement with the Regents of the University of California. CADx is an AI software tool that analyzes medical images to estimate malignancy likelihood and support radiologists in interpreting scans. In breast imaging, CADx is being developed to address limitations of mammography, digital breast tomosynthesis, ultrasound, and MRI by detecting subtle abnormalities, improving diagnostic consistency, reducing read…

Continue Reading